<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: To explore the immunophenotype of myeloid cells in <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> and its clinical implications </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: A panel of monoclonal antibodies was used to detect CD13, CD33, CD15 and CD14 on the membrane surfaces of myeloid cells in the bone marrow from 51 patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), 21 with <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (AA), 21 with <z:hpo ids='HP_0004818'>paroxysmal nocturnal hemoglobinuria</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>), and 15 <z:mpath ids='MPATH_458'>normal</z:mpath> subjects, by immunoenzymatic assay </plain></SENT>
<SENT sid="2" pm="."><plain>The <z:mp ids='MP_0000002'>morphology</z:mp> and chromosome karyotype of bone marrow cells of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients were also examined </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: CD14+ cells, CD13+ cells and CD33+ cells in the bone marrow were more in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients than in <z:mpath ids='MPATH_458'>normal</z:mpath> controls, AA patients and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> patients </plain></SENT>
<SENT sid="4" pm="."><plain>CD15+ cells in the bone marrow were less in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients than in <z:mpath ids='MPATH_458'>normal</z:mpath> controls </plain></SENT>
<SENT sid="5" pm="."><plain>The percentages of CD14, CD13 and CD33 positive cells in the bone marrow of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients were related to the percentage of myeloblast, the chromosomal aberrations and the response to treatment </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: There was an immunophenotypic misexpression of myeloid cells in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients </plain></SENT>
<SENT sid="7" pm="."><plain>Immunophenotype analysis of myeloid cells might be useful for the diagnosis and directing treatment in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients </plain></SENT>
</text></document>